Christopher Posner - Feb 8, 2024 Form 4 Insider Report for Cara Therapeutics, Inc. (CARA)

Role
PRESIDENT AND CEO, Director
Signature
/s/ Darren DeStefano, Attorney-in-Fact
Stock symbol
CARA
Transactions as of
Feb 8, 2024
Transactions value $
-$18,855
Form type
4
Date filed
2/12/2024, 05:10 PM
Previous filing
Feb 5, 2024
Next filing
Mar 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CARA Common Stock Sale -$18.9K -35.6K -16.03% $0.53 186K Feb 8, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person on November 2, 2022 in accordance with Rule 10b5-1 to satisfy the tax withholding obligations triggered by the vesting of restricted stock units and does not represent a discretionary trade by the Reporting Person.